You are viewing: Australia Veterinary Contract Manufacturing & Research Market analysis

The Australia Veterinary Contract Manufacturing & Research Market was valued at $19.2 Million in 2026 and projected to reach to $29.2 Million by 2031, representing a compound annual growth rate of 8.7%. Australia's veterinary contract manufacturing and research market is positioned for sustained growth through 2031, driven by the country's reputation for quality, regulatory compliance, and specialized expertise in veterinary pharmaceuticals.

Australia Veterinary Contract Manufacturing & Research Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Veterinary Contract Manufacturing & Research Market Trends and Insights

  • This expansion reflects Australia's strengthening position in the Asia Pacific region as a hub for specialized veterinary pharmaceutical development and manufacturing services.
  • Australia's market growth outpaces the global average, driven by increasing demand for contract research organization (CRO) services and manufacturing capabilities tailored to livestock and companion animal health sectors. The Australian market benefits from the country's advanced regulatory framework, skilled workforce, and proximity to key Asia Pacific markets.
  • Australia's veterinary contract manufacturing sector is increasingly attracting investment from multinational pharmaceutical companies seeking reliable outsourcing partners.
  • Between 2026 and 2031, Australia is expected to consolidate its role as a preferred destination for veterinary drug development, clinical trials, and manufacturing services, supported by growing livestock industries and rising pet ownership across the region..

Key Market Statistics

  • CAGR (2026-2031) 8.7% CAGR
  • Market Size, 2026 ~USD 19.2 Million
  • Forecast, 2031 ~USD 29.2 Million
  • Country Australia

Australia Veterinary Contract Manufacturing & Research Market Overview

Strong CAGR Performance :

Australia's veterinary contract manufacturing market is growing at 8.7% CAGR from 2026-2031, outpacing the global average of 7.7%, demonstrating the country's accelerating importance in the sector.

Significant Market Expansion :

The market is projected to grow from USD 19.2 million in 2026 to USD 29.2 million by 2031, representing a 52% increase over five years and reflecting strong demand for specialized veterinary services.

Asia-Pacific Hub Status :

Australia is establishing itself as a key regional hub for veterinary pharmaceutical development and manufacturing in Asia-Pacific, attracting investment and partnerships from global players seeking regional expertise.

Specialized Service Growth :

The expansion reflects increasing demand for specialized veterinary pharmaceutical development, contract research, and manufacturing services driven by Australia's regulatory expertise and quality standards.

Australia Veterinary Contract Manufacturing & Research Market Dynamics

  • The market's outperformance relative to global growth rates reflects Australia's strategic advantages as a regional manufacturing and research hub, supported by strong government backing for life sciences innovation and increasing partnerships with international pharmaceutical companies seeking Asia-Pacific capabilities. The sector is expected to benefit from rising demand for companion animal healthcare products, livestock pharmaceuticals, and specialized contract research services across the region.
  • Australia's skilled workforce, advanced manufacturing infrastructure, and stringent quality standards position local contract manufacturers to capture growing opportunities from both domestic and international clients seeking reliable, compliant veterinary pharmaceutical solutions..

Related Ecosystem

Animal Health

Top Technologies
    Top Companies

      Key Takeaways

      • Australia's veterinary contract manufacturing market is valued at USD 19.2 million in 2026, with a projected CAGR of 8.7% through 2031.
      • Australia's market growth rate exceeds the global CAGR of 7.7%, positioning the country as a high-growth segment within Asia Pacific.
      • Australia's regulatory expertise and manufacturing infrastructure attract multinational veterinary pharmaceutical companies seeking outsourcing partnerships.
      • Australia's market expansion is driven by rising demand for livestock health solutions and companion animal pharmaceuticals across the Asia Pacific region.

      Veterinary Contract Manufacturing & Research Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CDMO SERVICES (Service)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.7% from 2026 to 2031
      Largest Segment CDMO SERVICES (Service)
      Market Size Base Year (Billions) ~USD 6.38 (2026)
      Revenue Forecast (Billions) ~USD 9.24 (2031)
      Segments Covered Service, Type

      Australia Veterinary Contract Manufacturing & Research Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Service

      • Cdmo Services
      • Cro Services

      By Type

      • Analytical & Bioanalytical Services And Quality Assurance
      • Discovery & Pre-Clinical Studies
      • Manufacturing
      • Packaging & Labeling
      • Process Api & Formulation Development
      • Quality/Stability & Post-Market Support
      • Regulatory Affairs & Consulting
      • Veterinary Clinical Trials

      AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS6.26.87.48.18.89.610.511.49.2
      MULTINATIONAL ANIMAL HEALTH COMPANIES7.47.98.499.710.311.111.87
      START-UPS & VETERINARY BIOTECH FIRMS2.733.43.84.24.75.35.911.8
      TOTAL16.317.719.220.922.724.726.829.28.7

      Target Audience

      • Contract Manufacturing Organizations (CMOs) : CMOs need Australia-specific market data to evaluate expansion opportunities, understand competitive dynamics, and identify growth segments in the region's veterinary pharmaceutical manufacturing sector.
      • Pharmaceutical & Biotech Companies : Pharma companies seeking contract manufacturing partners in Asia-Pacific require detailed Australia market insights to assess outsourcing opportunities and identify reliable local service providers.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Australia's life sciences sector need market sizing, growth projections, and competitive landscape data to support due diligence and portfolio decisions.
      • Regulatory & Compliance Consultants : Consultants advising clients on veterinary pharmaceutical manufacturing in Australia require market-specific data on regulatory environment, quality standards, and competitive positioning.
      • Market Research & Strategy Teams : Corporate strategy and market research teams need Australia-focused veterinary contract manufacturing data to inform business development, competitive analysis, and regional market entry strategies.

      Reasons to Buy this Report

      • Market Size & Growth Data : Access precise valuation of Australia's veterinary contract manufacturing market with verified 2026-2031 projections, enabling accurate financial forecasting and investment decision-making for regional expansion.
      • Competitive Positioning Intelligence : Understand Australia's 8.7% CAGR advantage over global 7.7% growth, identifying why the market is outperforming and what competitive advantages local and international players can leverage.
      • Regional Hub Opportunity Analysis : Gain insights into Australia's emerging role as an Asia-Pacific hub for veterinary pharmaceutical services, revealing partnership and market entry opportunities for contract manufacturers and service providers.
      • Sector-Specific Demand Drivers : Identify key growth catalysts specific to Australia including regulatory frameworks, manufacturing capabilities, and specialized service demand that inform strategic planning and resource allocation.
      • Investment & Expansion Strategy : Leverage Australia-specific market data to evaluate expansion feasibility, assess competitive landscape, and identify high-potential segments for veterinary pharmaceutical manufacturing and research services.

      Frequently asked questions

      What is the current market size of veterinary contract manufacturing in Australia?

      Australia's veterinary contract manufacturing and research market is valued at USD 19.2 million in 2026, with expectations to grow to USD 29.2 million by 2031.

      What is the projected growth rate for Australia's veterinary contract manufacturing market?

      Australia's market is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031, outpacing the global average of 7.7%.

      Why is Australia becoming a hub for veterinary contract manufacturing?

      Australia's advanced regulatory framework, skilled workforce, quality infrastructure, and strategic location in the Asia Pacific region make it an attractive destination for veterinary pharmaceutical companies seeking reliable outsourcing partners.

      What sectors drive demand for veterinary contract manufacturing in Australia?

      Australia's market is driven by growing livestock industries, rising pet ownership, increasing demand for companion animal pharmaceuticals, and expansion of contract research organization (CRO) services across the region.

      How does Australia's market growth compare to the global veterinary contract manufacturing market?

      Australia's CAGR of 8.7% exceeds the global CAGR of 7.7%, indicating that Australia is a faster-growing market segment within the global veterinary contract manufacturing and research industry.

      RESEARCH METHODOLOGY

      This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

      Secondary Research

      This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

      Primary Research

      In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

      Veterinary Contract Manufacturing and Research Market 
 Size, and Share

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 2: Other designations include sales, marketing, and product/service managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Veterinary Contract Manufacturing and Research Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

      Market Definition

      The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.

      These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

      Key Stakeholders

      • Animal-health pharmaceutical companies
      • Veterinary biotechnology companies
      • Veterinary biologics & vaccine developers
      • Veterinary contract development & manufacturing organizations (CDMOs)
      • Veterinary contract research organizations (CROs)
      • Preclinical & toxicology research laboratories (GLP & non-GLP)
      • Clinical trial management organizations for veterinary studies
      • Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
      • Quality control & analytical testing laboratories (veterinary-focused)
      • Veterinary formulation & process development service providers
      • Packaging, filling, and labeling service providers for veterinary products
      • Animal research facilities & field trial centers
      • Veterinary academic research institutes
      • Livestock research institutions & herd-health trial networks
      • Raw material suppliers for veterinary APIs, excipients, and biologics components

      Report Objectives

      • To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

      Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
      • Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
      Competitive Landscape Assessment
      • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Veterinary Contract Manufacturing & Research Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status